Park Sooyoung, the opposition party floor leader for the Special Committee on the National Assembly's Special Act on Investment in the United States, is explaining the proposal for the Special Act on Strategic Investment Management between Korea and the United States (Special Act on Investment in the United States) at the plenary session of the March extraordinary session of the National Assembly. Photo by Yonhap News

Park Sooyoung, the opposition party floor leader for the Special Committee on the National Assembly's Special Act on Investment in the United States, is explaining the proposal for the Special Act on Strategic Investment Management between Korea and the United States (Special Act on Investment in the United States) at the plenary session of the March extraordinary session of the National Assembly. Photo by Yonhap News

View original image

On April 7 (local time), Jamieson Greer, representative of the Office of the United States Trade Representative (USTR), mentioned the semiconductor and generic drug sectors in relation to investments from Korea and Japan into the United States. These are interpreted as areas where the U.S. is seeking to attract investment.


According to the Hudson Institute, a U.S. think tank, Greer responded to a question during a discussion event at the Hudson Institute about whether he was satisfied with the pace of investment commitments from Japan and Korea into the United States, saying, "There has never been a situation where the President says, 'Everything is great and exactly on schedule.'"


Greer went on to explain, "There was a slight delay in Korea taking the necessary steps, but it has now been completed," adding, "There are some specific trade issues related (between Korea and the United States) that are in the process of being finalized." This appears to refer to the passage of the Special Act on Investment in the United States in Korea on March 12.


He further stated that Korea and Japan are consulting with the U.S. Department of Commerce on investment areas in the United States, noting, "In some cases, the focus is on generic drugs, and in other cases, it is on semiconductors."


Greer also mentioned, "Taiwan has made similar investment commitments," adding, "With regard to the progress of these investments, we are looking to focus on key core sectors."


The Korean government, following the passage of the Special Act on Investment in the United States in the National Assembly, has established an implementation committee to conduct preliminary reviews and consultations. The strategic industrial sectors for investment in the United States include semiconductors, pharmaceuticals, critical minerals, energy, and fields such as AI and quantum computing.


Additionally, Greer announced plans to resolve as many issues as possible under the United States-Mexico-Canada Agreement (USMCA) before July 1.


He explained that automobile, steel, and aluminum imports into the United States from Mexico and Canada have increased significantly, which has caused President Trump to be dissatisfied with the USMCA. Greer noted that measures for withdrawal from the USMCA might be necessary. However, it is known that the withdrawal process would take 10 years.


The USMCA, which replaced the North American Free Trade Agreement (NAFTA), was concluded on September 30, 2018, and, after some revisions, came into effect on July 1, 2020. If there are changes to the USMCA, this could also affect Korean companies that have been exporting to the United States tariff-free under the agreement.



Furthermore, Greer stated that economic relations between the United States and China are currently stable, and President Trump aims to maintain this stability at the May summit with Chinese President Xi Jinping.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing